Titelia

Holdings of Squadron Capital Management LLC

· Original filing · Compare with another fund · Report an error

Net assets
-
Positions
26 in 3 countries
Top ten
78.3 % of the equity sleeve
Filed on
Mar 31, 2026
Portfolio shape

Positions

RankCompanySharesValueWeight
1Relmada Therapeutics Inc 8,474,57159M $
2Cogent Biosciences Inc 787,49230.3M $
3KalVista Pharmaceuticals Inc 985,10019.8M $
4Kodiak Sciences Inc 380,00014.5M $
5Abivax SA 130,00014.5M $
6Edgewise Therapeutics Inc 350,00011M $
7Nektar Therapeutics 125,0009M $
8Adlai Nortye Ltd. 1,265,2318.8M $
9Zentalis Pharmaceuticals Inc 3,631,0008.5M $
10Maze Therapeutics Inc 257,5007.7M $
11SCYNEXIS INC 7,608,6957M $
12Relay Therapeutics Inc 672,5006.7M $
13C4 Therapeutics Inc 2,250,0005.9M $
14Inhibikase Therapeutics Inc 3,500,0005.9M $
15Palisade Bio Inc 3,000,0005.3M $
16Lipocine Inc 450,0003.6M $
17Inventiva SACA 535,0003M $
18ALX Oncology Holdings Inc 1,460,0002.9M $
19Context Therapeutics Inc 1,100,0002.9M $
20NextCure Inc 265,0002.8M $
21PASITHEA THERAPEUTICS CORP 2,100,0001.6M $
22TRAWS PHARMA INC 511,714936.4K $
23TherapeuticsMD Inc 420,421849.3K $
24SPRUCE BIOSCIENCES INC 12,200797.3K $
25WEREWOLF THERAPEUTICS INC 563,535469.2K $
26NEUPHORIA THERAPEUTICS INC 76,728312.3K $

Download this table: CSV, JSON

Sector breakdown

  • Unattributed 100.0 %

Titelia classification, company by company. The unattributed share stays visible.

Currency breakdown

  • USD 100.0 %

The quoted currency of each line, as declared.

Country breakdown

  • United States 88.8 %
  • France 7.5 %
  • Cayman Islands 3.7 %

Shares computed on the equity sleeve.

RankCountryLinesValueShare
1United States23207.7M $88.80 %
2France217.4M $7.46 %
3Cayman Islands18.8M $3.74 %
Cite this page

Titelia. "Holdings of Squadron Capital Management LLC". https://titelia.com/en/funds/US13F2050709